{"id":1077,"date":"2015-09-22T11:46:06","date_gmt":"2015-09-22T11:46:06","guid":{"rendered":"http:\/\/www.peptonicmedical.se\/?page_id=1077"},"modified":"2022-11-27T15:46:32","modified_gmt":"2022-11-27T15:46:32","slug":"start-new","status":"publish","type":"page","link":"https:\/\/www.peptonicmedical.se\/en\/start-new\/","title":{"rendered":"Home page OLD"},"content":{"rendered":"

[vc_row el_class=”three-cols-row”][vc_column width=”1\/3″ el_class=”col1″][vc_column_text]<\/p>\n

Learn more about \u0003our products \u00bb<\/a><\/h3>\n

[\/vc_column_text][\/vc_column][vc_column width=”1\/3″ el_class=”col2″][vc_column_text]<\/p>\n

About oxytocin \u00bb<\/a><\/h3>\n

[\/vc_column_text][\/vc_column][vc_column width=”1\/3″ el_class=”col3″][vc_column_text]<\/p>\n

Vaginal atrophy \u0003in the menopause \u00bb<\/a><\/h3>\n

[\/vc_column_text][\/vc_column][\/vc_row][vc_row el_class=”content”][vc_column width=”2\/3″ el_class=”left”][vc_column_text el_class=”border”]<\/p>\n

\"Analysguiden<\/a><\/div>\n

Analys Peptonic Medical: F\u00f6rb\u00e4ttrar f\u00f6rs\u00e4ljning och resultat v\u00e4sentligt<\/h2>\n

Peptonic Medical \u00f6kade oms\u00e4ttningen med 13% under H1 2022 till 21,3 mkr. Den nya strategin med kliniskt bevisad egenv\u00e5rd efter principen diagnostisera-behandla-f\u00f6rebygg m\u00f6ter en stark samh\u00e4llstrend som avspeglas i en v\u00e4xande f\u00f6rs\u00e4ljning och stark orderstock. Bolaget \u00e4r i en expansionsfas och v\u00e4ntas vara l\u00f6nsamma fr\u00e5n 2025. Som bolaget kommunicerade i sin Q1-rapport finns ytterligare framtida finansieringsbehov.<\/p>\n

L\u00e4s hela analysen \u00bb<\/a>[\/vc_column_text][vc_column_text el_class=”border”]<\/p>\n

\"Peptonic<\/a><\/div>\n

VD Erik Sundquist p\u00e5 Sm\u00e5bolagsdagarn 15 juni<\/h2>\n

Peptonic deltog p\u00e5 Sm\u00e5bolagsdagarna i Stockholm den 15 juni. VD Erik Sundquist presenterade bolaget och ber\u00e4ttade om vad som \u00e4r p\u00e5 g\u00e5ng fram\u00e5t.<\/p>\n

Se videon \u00bb<\/a>[\/vc_column_text][vc_column_text el_class=”border”]<\/p>\n

Kallelse till ordinarie \u00e5rsst\u00e4mma med PEPTONIC medical AB<\/h2>\n

Aktie\u00e4garna i PEPTONIC medical AB (publ) kallas h\u00e4rmed till \u00e5rsst\u00e4mma tisdagen den 24 maj 2022 kl.15.00 i Alviksstrand konferens.<\/p>\n

Se hela kallesen \u00bb<\/a>[\/vc_column_text][vc_column_text el_class=”border”]<\/p>\n

\"Peptonic<\/a><\/div>\n

VD Erik Sundquist p\u00e5 Aktiedagen 15 mars<\/h2>\n

Peptonic deltog p\u00e5 Aktiedagen i Stockholm den 15 mars. VD Erik Sundquist presenterade bolaget och ber\u00e4ttade om vad som \u00e4r p\u00e5 g\u00e5ng fram\u00e5t.<\/p>\n

Se videon \u00bb<\/a>[\/vc_column_text][vc_column_text el_class=”border”]<\/p>\n

\"Peptonic<\/div>\n

Peptonic Medical presenterar p\u00e5 Aktiespararnas Aktiedag i Stockholm\u00a015\/3<\/h2>\n

Efter Pandemin s\u00e4ger 65% att de \u00e4r mer ben\u00e4gna att sk\u00f6ta sin h\u00e4lsa sj\u00e4lva genom egenv\u00e5rdsprodukter. 82% vill att dessa egenv\u00e5rdsprodukter skall vara kliniskt bepr\u00f6vade.\u00a0Peptonic Medical \u00e4r mycket v\u00e4l positionerade f\u00f6r att m\u00f6ta denna trend. Kom och lyssna p\u00e5\u00a0VD Erik Sundquist n\u00e4r han presentera Peptonic och svarar p\u00e5 fr\u00e5gor om bolaget.<\/p>\n

Mer information om eventet \u00bb<\/a>
\nL\u00e4nk till lives\u00e4ndning \u00bb<\/a>[\/vc_column_text][\/vc_column][vc_column width=”1\/3″ el_class=”right”][vc_widget_sidebar sidebar_id=”aktietorget_feed” el_class=”press”][vc_wp_posts title=”Press releases & corporate news” number=”16″ show_date=”1″][vc_column_text el_class=”hide”]\"Email_Symbol\"
\nSubscribe to our newsletter \u00bb<\/a>[\/vc_column_text][vc_column_text]All press releases and news \u00bb<\/a>[\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n<\/section>","protected":false},"excerpt":{"rendered":"

[vc_row el_class=”three-cols-row”][vc_column width=”1\/3″ el_class=”col1″][vc_column_text] Learn more about \u0003our products \u00bb [\/vc_column_text][\/vc_column][vc_column width=”1\/3″ el_class=”col2″][vc_column_text] About oxytocin \u00bb [\/vc_column_text][\/vc_column][vc_column width=”1\/3″ el_class=”col3″][vc_column_text] Vaginal atrophy \u0003in the menopause \u00bb [\/vc_column_text][\/vc_column][\/vc_row][vc_row el_class=”content”][vc_column width=”2\/3″ el_class=”left”][vc_column_text el_class=”border”] Analys Peptonic Medical: F\u00f6rb\u00e4ttrar f\u00f6rs\u00e4ljning och resultat v\u00e4sentligt Peptonic Medical \u00f6kade oms\u00e4ttningen med 13% under H1 2022 till 21,3 mkr. Den nya strategin med kliniskt […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"_links":{"self":[{"href":"https:\/\/www.peptonicmedical.se\/en\/wp-json\/wp\/v2\/pages\/1077"}],"collection":[{"href":"https:\/\/www.peptonicmedical.se\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.peptonicmedical.se\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.peptonicmedical.se\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.peptonicmedical.se\/en\/wp-json\/wp\/v2\/comments?post=1077"}],"version-history":[{"count":75,"href":"https:\/\/www.peptonicmedical.se\/en\/wp-json\/wp\/v2\/pages\/1077\/revisions"}],"predecessor-version":[{"id":5075,"href":"https:\/\/www.peptonicmedical.se\/en\/wp-json\/wp\/v2\/pages\/1077\/revisions\/5075"}],"wp:attachment":[{"href":"https:\/\/www.peptonicmedical.se\/en\/wp-json\/wp\/v2\/media?parent=1077"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}